Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery

TY - JOUR

T1 - Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery

AU - Hoff, Steven

AU - Authors, Additional

N1 - Neither angiotensin-converting enzyme inhibition nor mineralocorticoid receptor blockade decreased the primary outcome of postoperative atrial fibrillation. Treatment with an angiotensin-converting enzyme inhibitor or mineralocorticoid receptor antagonist was associated with decreased acute renal fa ...

PY - 2012/10

Y1 - 2012/10

UR - https://pubmed.ncbi.nlm.nih.gov/22824930/

M3 - Article

VL - 40

JO - Critical Care Medicine

JF - Critical Care Medicine

ER -